1. Home
  2. STRS vs ABOS Comparison

STRS vs ABOS Comparison

Compare STRS & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$19.70

Market Cap

220.4M

Sector

Real Estate

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.14

Market Cap

197.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
ABOS
Founded
1992
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.4M
197.9M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
STRS
ABOS
Price
$19.70
$2.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
102.9K
362.6K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
512.50
N/A
EPS
0.82
N/A
Revenue
$29,914,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.53
$1.19
52 Week High
$32.93
$3.60

Technical Indicators

Market Signals
Indicator
STRS
ABOS
Relative Strength Index (RSI) 16.48 42.44
Support Level $18.51 $2.13
Resistance Level $20.57 $2.45
Average True Range (ATR) 0.74 0.16
MACD 0.01 -0.02
Stochastic Oscillator 24.02 10.61

Price Performance

Historical Comparison
STRS
ABOS

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: